Timing of Suture Removal to Reduce Scarring in Skin Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a single centre prospective randomized assessor blinded parallel group feasibility study that will be undertaken in the Royal Devon and Exeter Dermatology department. The investigators will be looking at whether timing of percutaneous suture removal after skin surgery impacts on the incidence of suture marks and overall scar cosmesis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2021
CompletedFirst Posted
Study publicly available on registry
September 8, 2021
CompletedStudy Start
First participant enrolled
December 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 26, 2022
CompletedResults Posted
Study results publicly available
October 24, 2024
CompletedOctober 24, 2024
September 1, 2023
11 months
August 26, 2021
September 4, 2023
October 23, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The Measured Difference in POSAS and VAS Scores Between 7-day and 10-day Groups
In patients undergoing wide local excision and primary wound closure for treatment of skin cancer does earlier removal of percutaneous sutures (7 days rather than 10 days) reduce the incidence of suture marks assessed at 3 months post-operatively. The patient and observer scar assessment scale (POSAS) was used. The patient POSAS was comprised of a score between 1-10 each for pain, itch, colour, stiffness, thickness and irregularity. The observer POSAS was comprised of a score between 1-10 each for vascularity, pigmentation, thickness, relief, pliability and surface area. 1 being normal skin and 10 abnormal skin. The total POSAS scores for both patients/observers were calculated by adding these up, with min/max 1-60. Higher scores equating to worse outcomes. A visual analogue scale (VAS) was used (min/max 1 to 10) to assess the appearance of suture marks, with 1 being normal skin and 10 being abnormal.
3 months
Secondary Outcomes (1)
Does Earlier Suture Removal Have an Impact (Negative or Positive) on Overall Scar Cosmesis and Wound Complication Rates (as Assessed by the Clinician and the Patient)?
3 months
Study Arms (2)
Suture removal at 7 days
ACTIVE COMPARATORSuture removal at 7 days post skin surgery
Suture removal at 10 days
ACTIVE COMPARATORSuture removal at 10 days post skin surgery
Interventions
Patients will either be randomized to have their sutures removed at 7 or 10 days post skin surgery
Eligibility Criteria
You may qualify if:
- Patients of 18 years old or above who had capacity to consent to surgery who were willing to attend follow-up appointments within the department
- Patients undergoing wide local excision as part of their skin cancer treatment pathway
- Lesions excised from the anterior chest or back
- Post-operative wound \>/= 10mm width
- Wound could be closed with primary intention healing
You may not qualify if:
- Inability to provide valid informed consent and/or unwilling to attend for follow-up
- Wounds where the edges could not be closely adhered with dermal sutures alone.
- Wounds requiring a flap or graft for closure.
- Patients requiring further treatment following original excision eg. Further WLE, radiotherapy etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Devon and Exeter Heavitree Hospital
Exeter, United Kingdom
Related Publications (9)
Weitemeyer MB, Bramsen P, Klausen TW, Holmich LR, Gjorup CA. Patient-and observer-reported long-term scar quality of wide local excision scars in melanoma patients. J Plast Surg Hand Surg. 2018 Dec;52(6):319-324. doi: 10.1080/2000656X.2018.1493388. Epub 2018 Oct 31.
PMID: 30380964BACKGROUNDProwse, Phoebe & Shokrollahi, Kayvan. (2014). Leaving our mark - are suture marks acceptable?. Bulletin of The Royal College of Surgeons of England. 96. 264-266. 10.1308/147363514X14042954768637.
BACKGROUNDCRIKELAIR GF. Skin suture marks. Am J Surg. 1958 Nov;96(5):631-9. doi: 10.1016/0002-9610(58)90464-1. No abstract available.
PMID: 13583327BACKGROUNDMoy RL, Waldman B, Hein DW. A review of sutures and suturing techniques. J Dermatol Surg Oncol. 1992 Sep;18(9):785-95. doi: 10.1111/j.1524-4725.1992.tb03036.x.
PMID: 1512311BACKGROUNDHasan Z, Gangopadhyay AN, Gupta DK, Srivastava P, Sharma SP. Sutureless skin closure with isoamyl 2-cyanoacrylate in pediatric day-care surgery. Pediatr Surg Int. 2009 Dec;25(12):1123-5. doi: 10.1007/s00383-009-2485-9. Epub 2009 Sep 17.
PMID: 19760198BACKGROUNDHohenleutner U, Egner N, Hohenleutner S, Landthaler M. Intradermal buried vertical mattress suture as sole skin closure: evaluation of 149 cases. Acta Derm Venereol. 2000 Sep-Oct;80(5):344-7. doi: 10.1080/000155500459277.
PMID: 11200831BACKGROUNDWolf R. Serial replacement of sutures for preventing suture marks. J Dermatol Surg Oncol. 1993 Dec;19(12):1131. doi: 10.1111/j.1524-4725.1993.tb02477.x. No abstract available.
PMID: 8282914BACKGROUNDKobayashi S, Ito M, Yamamoto S, Kinugasa Y, Kotake M, Saida Y, Kobatake T, Yamanaka T, Saito N, Moriya Y. Randomized clinical trial of skin closure by subcuticular suture or skin stapling after elective colorectal cancer surgery. Br J Surg. 2015 Apr;102(5):495-500. doi: 10.1002/bjs.9786. Epub 2015 Feb 26.
PMID: 25727933BACKGROUNDViechtbauer W, Smits L, Kotz D, Bude L, Spigt M, Serroyen J, Crutzen R. A simple formula for the calculation of sample size in pilot studies. J Clin Epidemiol. 2015 Nov;68(11):1375-9. doi: 10.1016/j.jclinepi.2015.04.014. Epub 2015 Jun 6.
PMID: 26146089BACKGROUND
Results Point of Contact
- Title
- Dr Ellen Richards
- Organization
- Royal Devon and Exeter NHS Trust
Study Officials
- PRINCIPAL INVESTIGATOR
Emily McGrath, BMedSci BMBS
Royal Devon and Exeter NHS Trust
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2021
First Posted
September 8, 2021
Study Start
December 7, 2021
Primary Completion
October 26, 2022
Study Completion
October 26, 2022
Last Updated
October 24, 2024
Results First Posted
October 24, 2024
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share